Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XREWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-11629.5South Korea
XREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XRECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22146.3Germany
XRECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XREHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XREHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XRENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XRENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.350.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.350.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.350.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.350.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.350.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.350.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.350.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.254EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.254EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.254ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.254ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.254EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.254EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.254ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.254ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.1.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.39.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.1 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.39.1.1 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.39.1.1 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.39.1.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.39.1.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.39.1.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.418EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used